MyFinsight
Home
Blog
About
Back
Income Statement
Contineum Therapeutics, Inc. (CTNM)
Contineum Therapeutics, Inc. (CTNM)
source: myfinsight.com
Comprehensive loss
-$15,474K
Interest income
$2,342K
(15.43%↑ Y/Y)
Net loss
-$15,154K
(5.52%↑ Y/Y)
Unrealized loss (gain) on
marketable securities
-$320K
Total other income,
net
$2,274K
Other expense, net
-$68K
Loss from operations
-$17,428K
Total operating
expenses
$17,428K
Research and development
$12,702K
General and
administrative
$4,726K
(23.10%↑ Y/Y)
Back